Vitamin K antagonist embryofetopathy

Vitamin K antagonist embryofetopathy, also known as warfarin embryopathy or fetal warfarin syndrome, is a rare congenital disorder caused by prenatal exposure to vitamin K antagonist anticoagulants (most commonly warfarin) during pregnancy. It is not an inherited genetic condition but rather a teratogenic effect resulting from the medication crossing the placenta and interfering with vitamin K-dependent processes critical for fetal development, particularly the carboxylation of osteocalcin and other matrix proteins essential for bone and cartilage formation. The condition primarily affects the skeletal system, central nervous system, and facial structures. The classic features include nasal hypoplasia (underdevelopment of the nasal bridge), stippled epiphyses (punctate calcifications in cartilage visible on X-ray), and limb abnormalities such as shortened fingers and limbs. Exposure during the first trimester, particularly between weeks 6 and 9 of gestation, is most strongly associated with the characteristic skeletal and facial features. Second and third trimester exposure can lead to central nervous system abnormalities including microcephaly, intellectual disability, optic atrophy, hydrocephalus, and seizures, as well as eye anomalies. Some affected individuals may also experience hearing loss and growth restriction. There is no specific cure for vitamin K antagonist embryofetopathy. Management is supportive and multidisciplinary, addressing the individual clinical manifestations. Orthopedic interventions may be needed for skeletal abnormalities, and neurodevelopmental support is important for children with central nervous system involvement. Prevention is the cornerstone of management: women of childbearing age requiring anticoagulation are typically counseled to switch from warfarin to alternative anticoagulants such as low-molecular-weight heparin before or early in pregnancy, as heparin does not cross the placenta.

Common questions about Vitamin K antagonist embryofetopathy